Bicara Therapeutics Inc. Common Stock (BCAX NASDAQ) stock market data APIs
$23.7263
0(0%)
as of September 2, 2026
Try our APIs with
free plan!
Bicara Therapeutics Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Prev. Close
23.7263
Open
23.7287
High
24.381
Low
22.8856
52 wk Range
10.295-30.99
Market Cap
1 550 M
Shares Outstanding
66 173 K
EPS
-0.82
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Bicara Therapeutics Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bicara Therapeutics Inc. Common Stock data using free add-ons & libraries
Get Bicara Therapeutics Inc. Common Stock Fundamental Data
Bicara Therapeutics Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -201 834 000
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Bicara Therapeutics Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-11
- EPS/Forecast: -0.77
Get Bicara Therapeutics Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bicara Therapeutics Inc. Common Stock News
New
Can Bicara (BCAX) Commercialize Ficera? Breakthrough 3-Year Data Faces Execution Risk in C-Suite Overhaul
On August 11, Bicara Therapeutics (NASDAQ:BCAX) used its second-quarter earnings call to deliver two headlines at once. CEO Claire Mazumdar announced she will step into a Vice Chair and Strategic Advi...
Bicara Therapeutics Q2 Net Loss Expands; Phase 3 FORTIFI-HN01 Study Enrollment On Track
(RTTNews) - Bicara Therapeutics Inc. (BCAX), a clinical-stage biopharmaceutical company, announced financial results for the second quarter reflecting a wider net loss. In addition, the company announ...
Bicara Therapeutics Inc. Common Stock Q2 2026 Earnings Call Summary
Bicara Therapeutics Inc. Common Stock Q2 2026 Earnings Call Summary - Moby Executive Narrative Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest a...
Bicara Therapeutics Q2 Earnings Call Highlights
Key Points Interested in Bicara Therapeutics Inc.? Here are five stocks we like better. FICERA's pivotal FORTIFI-HN01 trial remains on track for substantial enrollment by the end of 2026, with an int...
Get Bicara Therapeutics Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
